Researcher
Pieter Gillard
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 2009 → Today
Projects
1 - 10 of 10
- Technological improvements in the management of type 1 diabetesFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The road to personalized management of type 1 diabetes with a focus on closed-loop devicesFrom2 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The use of novel technologies with a focus on the individual needs of people living with type 1 diabetesFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Closed-loop insulin delivery in pregnant women with type 1 diabetes (the CRISTAL study)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research Grant, BOF - doctoral mandates
- Exploring the use of continuous glucose monitoring to improve glycemic control and quality of life in type 1 diabetesFrom1 Jan 2019 → 31 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Histology: a vital tool for endocrine and metabolic researchFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Identification of patient-specific parameters for bolus calculators in type 1 diabetic patientsFrom15 Aug 2016 → 31 Dec 2020Funding: FWO Strategic Basic Research Grant
- Robust identification of patient-specific parameters for bolus calculators in type 1 diabetic patientsFrom1 Oct 2015 → 30 Sep 2017Funding: IOF - Industrial Research Fund
- The beta-cell and the immune system in type 1 diabetes: partners in crime - developing new therapies in type 1 diabetes through better understanding of beta-cell behaviour and use of novel immunomodulators.From1 Oct 2013 → 30 Sep 2018Funding: BOF - Concerted Research Project from 1994
- Relation between residual beta cell function and glycemic variability in (pre)type 1 diabetes.From1 Jan 2011 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
Publications
41 - 50 of 116
- Use of hyperglycemic clamp to assess pancreatectomy and islet cell autotransplant in patient with heterotaxy syndrome and dorsal pancreas agenesis leading to chronic pancreatitis(2020)
Authors: Pieter Gillard, Geert Maleux, Vincent Vandecaveye, Yves Debaveye, Schalk Van der Merwe, Jacques Pirenne, Hannah van Malenstein
Pages: 3662 - 3666 - Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)(2020)
Authors: Pieter Gillard, Chantal Mathieu
Pages: 2501 - 2520 - Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scannedCGM(isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed byJDRFand supported by the American Diabetes Association (ADA)(2020)
Authors: Pieter Gillard, Chantal Mathieu
Pages: 1375 - 1393 - No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes(2020)
Authors: Roman Vangoitsenhoven, Pieter-Jan Martens, Pieter Gillard, Chantal Mathieu
Pages: E118 - E119 - Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials(2020)
Authors: Pieter Gillard, Chantal Mathieu
Pages: 845 - 854 - Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation in Type 1 Diabetes Patients(2020)
Authors: Pieter Gillard, Geert Maleux, Chantal Mathieu
Pages: E295 - E302 - Unrestricted use of intermittently-scanned continuous glucose monitoring in youth is associated with high satisfaction and less absence from school(2020)
Authors: Sara Charleer, Pieter Gillard, K Casteels
Pages: S338 - S339 - Chronic complications versus glycaemic variability, time in range and HbA(1c) in people with type 1 diabetes: sub study of the RESCUE-trial(2020)
Authors: A El Malahi, M Van Elsen, Sara Charleer, F De Ridder, K Ledeganck, B Keymeulen, L Crenier, R Radermecker, B Lapauw, C Vercammen, et al.
Pages: S19 - S19 - MiR-375 levels in newly diagnosed type 1 diabetes: results from a phase 2, multicentre, randomised, placebo controlled trial (MEX0114)(2020)
Authors: L Piemonti, V Lampasona, I Marzinotto, E Bosi, P Pozzilli, F Giorgino, E Cossu, T Linn, L Rose, B Keymeulen, et al.
Pages: S183 - S184 - Quality of life versus glycaemic variability and time in range in people with type 1 diabetes: sub study of the RESCUE-trial(2020)
Authors: Pieter Gillard, A El Malahi, M Van Elsen, Sara Charleer, F De Ridder, K Ledeganck, B Keymeulen, L Crenier, R Radermecker, B Lapauw, et al.
Pages: S371 - S372